U.S. market Closed. Opens in 1 day 10 hours 31 minutes

BLCO | Bausch + Lomb Corporation Stock Overview

(Stock Exchange: NYSE)
Day's Range 17.85 - 18.20
52 Week Range 13.16 - 21.69
Beta 0.69
Implied Volatility 56.50%
IV Rank 52.65%
Day's Volume 399,560
Average Volume 556,860
Shares Outstanding 352,164,030
Market Cap 6,338,952,540
Sector Healthcare
Industry Medical - Instruments & Supplies
IPO Date 2022-05-06
Valuation
Profitability
Growth
Health
P/E Ratio -17.31
Forward P/E Ratio N/A
EPS -1.04
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 13,000
Country Canada
Website BLCO
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
BLCO's peers: AZTA, COO, ICUI, HOLX, BDX, TFX, WST, ALC, RMD, AKYA, ATRC, ATRI, HAE, ANGO, ATR
*Chart delayed
Analyzing fundamentals for BLCO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see BLCO Fundamentals page.

Watching at BLCO technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on BLCO Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙